Xiromed debuts generic LibraxLibrax capsules and its generics had a market value of $100.5 million for the 12 months ended February 2021, according to IQVIA. FDA acting commissioner to deliver keynote speech at AAM’s virtual conferenceJanet Woodcock will share the latest FDA actions on quality initiatives, supply chain integrity, inspections during COVID-19, GDUFA III and BsUFA III, and innovation in the generic and biosimilars industry. Zydus Cadila receives FDA blessing for generic Opsumit Zydus is eligible for 180 days of shared generic drug exclusivity for generic Opsumit. Zydus Cadila obtains FDA nod for generic Imbruvica Zydus is the first company to receive approval for generic ibrutinib 70-mg capsules. Camber intros generic Urocit-K Camber's generic Urocit-K tablets provide a treatment for patients with a kidney stone condition called renal tubular acidosis. Dr. Reddy's intros generic Kuvan Dr. Reddy's generic Kuvan offers a treatment for a rare disease. Aurobindo launches generic Astelin Camber intros generic Quelicin Camber's generic Quelicin is used as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. FDA greenlights Aurobindo’s generic potassium chloride Aurobindo's generic potassium chloride ER tablets will be offered in dosage strengths of 10 mEq, 15 mEq, and 20 mEq. Mayne Pharma launches generic Ortho-Cept Mayne has now launched four generic oral contraceptives with a combined market value of roughly $315 million for the 12 months ending January 2021. First Previous 113 114 115 116 117 Next Last